1 | preserved | 3,553 |
2 | repaired | 540 |
3 | hypoplastic | 168 |
4 | well-preserved | 49 |
5 | supernormal | 29 |
6 | cmr-derived | 25 |
7 | subpulmonary | 21 |
8 | quadripolar | 20 |
9 | spectron | 16 |
10 | unidentifiable | 13 |
11 | ciniii | 11 |
12 | decelerative | 7 |
13 | ess-corrected | 6 |
14 | re-instituted | 5 |
15 | safetac | 5 |
16 | tako-tsubo-like | 5 |
17 | 1o | 4 |
18 | biscover | 4 |
19 | decongested | 4 |
20 | non-first-generation | 4 |
21 | om/am/hctz | 4 |
22 | tte-based | 4 |
23 | up-sloping | 4 |
24 | 2.70-fold | 3 |
25 | 3-17i-saporin | 3 |
26 | body-affecting | 3 |
27 | ethylenediamine-grafted | 3 |
28 | fatigue-predominant | 3 |
29 | kl2-3 | 3 |
30 | microthread | 3 |
31 | nonalbuminuric | 3 |
32 | normal-size | 3 |
33 | normonatremia | 3 |
34 | pc-cmr-derived | 3 |
35 | reduced-size | 3 |
36 | stress-adjusted | 3 |
37 | video-tape | 3 |
38 | 2-iodoaniline | 2 |
39 | 3.5g/l | 2 |
40 | adp-ma | 2 |
41 | at-normal | 2 |
42 | at/total | 2 |
43 | coghd | 2 |
44 | cohsasa | 2 |
45 | flatstent™ | 2 |
46 | ht-lsac | 2 |
47 | incident-isolated | 2 |
48 | intralipid-tg | 2 |
49 | lv/univentricular | 2 |
50 | milk-containing | 2 |
51 | non-fsw | 2 |
52 | oxcap+cetuximab | 2 |
53 | period/lv | 2 |
54 | period/rv | 2 |
55 | pm-derived | 2 |
56 | radionuclide-determined | 2 |
57 | septo-lateral | 2 |
58 | tunnel-type | 2 |
59 | 1.1±2.1 | 1 |
60 | 216±89 | 1 |
61 | 222±86 | 1 |
62 | 3'-hydroxyl-4'-methylphenyl | 1 |
63 | 3-estimated | 1 |
64 | 4-beat | 1 |
65 | 5.2-cm | 1 |
66 | 6.5-cm | 1 |
67 | 6701 | 1 |
68 | abbreviates | 1 |
69 | adhd-2 | 1 |
70 | age.systemic | 1 |
71 | anatomically-supposedly-normal | 1 |
72 | anormal | 1 |
73 | anti-tlqp-21 | 1 |
74 | antibody-depletion | 1 |
75 | aposttraumatic | 1 |
76 | bcis-rated | 1 |
77 | borderline-normal | 1 |
78 | bromoacetylarenes | 1 |
79 | carto-guided | 1 |
80 | cefotaxime/heparin | 1 |
81 | chromatography-with | 1 |
82 | cmri-derived | 1 |
83 | cone-corrected | 1 |
84 | content/high | 1 |
85 | copd+normal | 1 |
86 | crescendo-decresendo | 1 |
87 | diastolc | 1 |
88 | digitobrachial | 1 |
89 | dimished | 1 |
90 | doxazosin-s. | 1 |
91 | dyssychronous | 1 |
92 | dysynchronous | 1 |
93 | e/e'/peak | 1 |
94 | ecccentric | 1 |
95 | ecg-verified | 1 |
96 | echocardiography-assessed | 1 |
97 | egfr/human | 1 |
98 | epilepsy.the | 1 |
99 | fast-progressing | 1 |
100 | flatstent/flatstent | 1 |
101 | g3-persistent | 1 |
102 | golph3‑positive | 1 |
103 | homeothermia | 1 |
104 | hypertension/isolated | 1 |
105 | icd-detected | 1 |
106 | inferior-wall | 1 |
107 | infero-septal | 1 |
108 | inverse-probability-of-treatment-weighting | 1 |
109 | iss.we | 1 |
110 | laparoscópica | 1 |
111 | left-ventricular++ | 1 |
112 | low/reduced | 1 |
113 | m918t | 1 |
114 | maleimide-derived | 1 |
115 | manikin-trained | 1 |
116 | mass/total | 1 |
117 | mmhg/gram | 1 |
118 | msv/end | 1 |
119 | n120 | 1 |
120 | nighttime-to-daytime | 1 |
121 | non-enhancing | 1 |
122 | nonparticipators | 1 |
123 | noregestrel | 1 |
124 | not-in-small-cell | 1 |
125 | one-step-late | 1 |
126 | orange-reddish | 1 |
127 | oscarovic | 1 |
128 | pcr-eia-positive | 1 |
129 | pharmaburst | 1 |
130 | placebo/lower | 1 |
131 | post-cpr | 1 |
132 | potassium-arrested | 1 |
133 | pre-exiting | 1 |
134 | preserved/reduced | 1 |
135 | pseudophosphatase | 1 |
136 | radioantagonists | 1 |
137 | radionuclide-estimated | 1 |
138 | recombinase-induced | 1 |
139 | reduction/ideal | 1 |
140 | rvsp/systemic | 1 |
141 | salivaricin | 1 |
142 | salt-aversive | 1 |
143 | shadeeye | 1 |
144 | shifted-to-the | 1 |
145 | sma/aortic | 1 |
146 | solutol | 1 |
147 | spect-determined | 1 |
148 | sub-pulmonic | 1 |
149 | target-equivalent | 1 |
150 | technetium-99m-hmpao-hexamethly | 1 |
151 | thenoyltrifluoroacetone-functionalized | 1 |
152 | tigroid | 1 |
153 | time-global | 1 |
154 | time-regional | 1 |
155 | udma-tegdma | 1 |
156 | unsevered | 1 |
157 | v-pace-induced | 1 |
158 | variability-equivalent | 1 |
159 | voxelized | 1 |
160 | white/american | 1 |
161 | wild-type/mutated | 1 |
162 | yjj-101 | 1 |
163 | ↓lv | 1 |
164 | ≥jia-american | 1 |
1 | 1.1±2.1 | 1 |
2 | 1o | 4 |
3 | 2-iodoaniline | 2 |
4 | 2.70-fold | 3 |
5 | 216±89 | 1 |
6 | 222±86 | 1 |
7 | 3'-hydroxyl-4'-methylphenyl | 1 |
8 | 3-17i-saporin | 3 |
9 | 3-estimated | 1 |
10 | 3.5g/l | 2 |
11 | 4-beat | 1 |
12 | 5.2-cm | 1 |
13 | 6.5-cm | 1 |
14 | 6701 | 1 |
15 | abbreviates | 1 |
16 | adhd-2 | 1 |
17 | adp-ma | 2 |
18 | age.systemic | 1 |
19 | anatomically-supposedly-normal | 1 |
20 | anormal | 1 |
21 | anti-tlqp-21 | 1 |
22 | antibody-depletion | 1 |
23 | aposttraumatic | 1 |
24 | at-normal | 2 |
25 | at/total | 2 |
26 | bcis-rated | 1 |
27 | biscover | 4 |
28 | body-affecting | 3 |
29 | borderline-normal | 1 |
30 | bromoacetylarenes | 1 |
31 | carto-guided | 1 |
32 | cefotaxime/heparin | 1 |
33 | chromatography-with | 1 |
34 | ciniii | 11 |
35 | cmr-derived | 25 |
36 | cmri-derived | 1 |
37 | coghd | 2 |
38 | cohsasa | 2 |
39 | cone-corrected | 1 |
40 | content/high | 1 |
41 | copd+normal | 1 |
42 | crescendo-decresendo | 1 |
43 | decelerative | 7 |
44 | decongested | 4 |
45 | diastolc | 1 |
46 | digitobrachial | 1 |
47 | dimished | 1 |
48 | doxazosin-s. | 1 |
49 | dyssychronous | 1 |
50 | dysynchronous | 1 |
51 | e/e'/peak | 1 |
52 | ecccentric | 1 |
53 | ecg-verified | 1 |
54 | echocardiography-assessed | 1 |
55 | egfr/human | 1 |
56 | epilepsy.the | 1 |
57 | ess-corrected | 6 |
58 | ethylenediamine-grafted | 3 |
59 | fast-progressing | 1 |
60 | fatigue-predominant | 3 |
61 | flatstent/flatstent | 1 |
62 | flatstent™ | 2 |
63 | g3-persistent | 1 |
64 | golph3‑positive | 1 |
65 | homeothermia | 1 |
66 | ht-lsac | 2 |
67 | hypertension/isolated | 1 |
68 | hypoplastic | 168 |
69 | icd-detected | 1 |
70 | incident-isolated | 2 |
71 | inferior-wall | 1 |
72 | infero-septal | 1 |
73 | intralipid-tg | 2 |
74 | inverse-probability-of-treatment-weighting | 1 |
75 | iss.we | 1 |
76 | kl2-3 | 3 |
77 | laparoscópica | 1 |
78 | left-ventricular++ | 1 |
79 | low/reduced | 1 |
80 | lv/univentricular | 2 |
81 | m918t | 1 |
82 | maleimide-derived | 1 |
83 | manikin-trained | 1 |
84 | mass/total | 1 |
85 | microthread | 3 |
86 | milk-containing | 2 |
87 | mmhg/gram | 1 |
88 | msv/end | 1 |
89 | n120 | 1 |
90 | nighttime-to-daytime | 1 |
91 | non-enhancing | 1 |
92 | non-first-generation | 4 |
93 | non-fsw | 2 |
94 | nonalbuminuric | 3 |
95 | nonparticipators | 1 |
96 | noregestrel | 1 |
97 | normal-size | 3 |
98 | normonatremia | 3 |
99 | not-in-small-cell | 1 |
100 | om/am/hctz | 4 |
101 | one-step-late | 1 |
102 | orange-reddish | 1 |
103 | oscarovic | 1 |
104 | oxcap+cetuximab | 2 |
105 | pc-cmr-derived | 3 |
106 | pcr-eia-positive | 1 |
107 | period/lv | 2 |
108 | period/rv | 2 |
109 | pharmaburst | 1 |
110 | placebo/lower | 1 |
111 | pm-derived | 2 |
112 | post-cpr | 1 |
113 | potassium-arrested | 1 |
114 | pre-exiting | 1 |
115 | preserved | 3,553 |
116 | preserved/reduced | 1 |
117 | pseudophosphatase | 1 |
118 | quadripolar | 20 |
119 | radioantagonists | 1 |
120 | radionuclide-determined | 2 |
121 | radionuclide-estimated | 1 |
122 | re-instituted | 5 |
123 | recombinase-induced | 1 |
124 | reduced-size | 3 |
125 | reduction/ideal | 1 |
126 | repaired | 540 |
127 | rvsp/systemic | 1 |
128 | safetac | 5 |
129 | salivaricin | 1 |
130 | salt-aversive | 1 |
131 | septo-lateral | 2 |
132 | shadeeye | 1 |
133 | shifted-to-the | 1 |
134 | sma/aortic | 1 |
135 | solutol | 1 |
136 | spect-determined | 1 |
137 | spectron | 16 |
138 | stress-adjusted | 3 |
139 | sub-pulmonic | 1 |
140 | subpulmonary | 21 |
141 | supernormal | 29 |
142 | tako-tsubo-like | 5 |
143 | target-equivalent | 1 |
144 | technetium-99m-hmpao-hexamethly | 1 |
145 | thenoyltrifluoroacetone-functionalized | 1 |
146 | tigroid | 1 |
147 | time-global | 1 |
148 | time-regional | 1 |
149 | tte-based | 4 |
150 | tunnel-type | 2 |
151 | udma-tegdma | 1 |
152 | unidentifiable | 13 |
153 | unsevered | 1 |
154 | up-sloping | 4 |
155 | v-pace-induced | 1 |
156 | variability-equivalent | 1 |
157 | video-tape | 3 |
158 | voxelized | 1 |
159 | well-preserved | 49 |
160 | white/american | 1 |
161 | wild-type/mutated | 1 |
162 | yjj-101 | 1 |
163 | ↓lv | 1 |
164 | ≥jia-american | 1 |
1 | left-ventricular++ | 1 |
2 | doxazosin-s. | 1 |
3 | n120 | 1 |
4 | 1.1±2.1 | 1 |
5 | yjj-101 | 1 |
6 | 6701 | 1 |
7 | anti-tlqp-21 | 1 |
8 | adhd-2 | 1 |
9 | kl2-3 | 3 |
10 | 222±86 | 1 |
11 | 216±89 | 1 |
12 | laparoscópica | 1 |
13 | normonatremia | 3 |
14 | homeothermia | 1 |
15 | adp-ma | 2 |
16 | udma-tegdma | 1 |
17 | cohsasa | 2 |
18 | oxcap+cetuximab | 2 |
19 | ht-lsac | 2 |
20 | safetac | 5 |
21 | age.systemic | 1 |
22 | rvsp/systemic | 1 |
23 | sub-pulmonic | 1 |
24 | ecccentric | 1 |
25 | nonalbuminuric | 3 |
26 | aposttraumatic | 1 |
27 | sma/aortic | 1 |
28 | hypoplastic | 168 |
29 | oscarovic | 1 |
30 | diastolc | 1 |
31 | microthread | 3 |
32 | preserved/reduced | 1 |
33 | low/reduced | 1 |
34 | v-pace-induced | 1 |
35 | recombinase-induced | 1 |
36 | carto-guided | 1 |
37 | dimished | 1 |
38 | ecg-verified | 1 |
39 | manikin-trained | 1 |
40 | radionuclide-determined | 2 |
41 | spect-determined | 1 |
42 | unsevered | 1 |
43 | repaired | 540 |
44 | tte-based | 4 |
45 | echocardiography-assessed | 1 |
46 | incident-isolated | 2 |
47 | hypertension/isolated | 1 |
48 | 3-estimated | 1 |
49 | radionuclide-estimated | 1 |
50 | bcis-rated | 1 |
51 | wild-type/mutated | 1 |
52 | cone-corrected | 1 |
53 | ess-corrected | 6 |
54 | icd-detected | 1 |
55 | ethylenediamine-grafted | 3 |
56 | decongested | 4 |
57 | potassium-arrested | 1 |
58 | stress-adjusted | 3 |
59 | re-instituted | 5 |
60 | maleimide-derived | 1 |
61 | cmri-derived | 1 |
62 | pm-derived | 2 |
63 | cmr-derived | 25 |
64 | pc-cmr-derived | 3 |
65 | preserved | 3,553 |
66 | well-preserved | 49 |
67 | thenoyltrifluoroacetone-functionalized | 1 |
68 | voxelized | 1 |
69 | coghd | 2 |
70 | tigroid | 1 |
71 | 2.70-fold | 3 |
72 | msv/end | 1 |
73 | shifted-to-the | 1 |
74 | epilepsy.the | 1 |
75 | tako-tsubo-like | 5 |
76 | unidentifiable | 13 |
77 | nighttime-to-daytime | 1 |
78 | 2-iodoaniline | 2 |
79 | video-tape | 3 |
80 | tunnel-type | 2 |
81 | pseudophosphatase | 1 |
82 | one-step-late | 1 |
83 | salt-aversive | 1 |
84 | decelerative | 7 |
85 | pcr-eia-positive | 1 |
86 | golph3‑positive | 1 |
87 | iss.we | 1 |
88 | shadeeye | 1 |
89 | reduced-size | 3 |
90 | normal-size | 3 |
91 | non-enhancing | 1 |
92 | milk-containing | 2 |
93 | up-sloping | 4 |
94 | fast-progressing | 1 |
95 | body-affecting | 3 |
96 | inverse-probability-of-treatment-weighting | 1 |
97 | pre-exiting | 1 |
98 | intralipid-tg | 2 |
99 | content/high | 1 |
100 | orange-reddish | 1 |
101 | chromatography-with | 1 |
102 | ciniii | 11 |
103 | e/e'/peak | 1 |
104 | 3.5g/l | 2 |
105 | time-global | 1 |
106 | reduction/ideal | 1 |
107 | digitobrachial | 1 |
108 | copd+normal | 1 |
109 | borderline-normal | 1 |
110 | at-normal | 2 |
111 | anatomically-supposedly-normal | 1 |
112 | anormal | 1 |
113 | supernormal | 29 |
114 | time-regional | 1 |
115 | septo-lateral | 2 |
116 | mass/total | 1 |
117 | at/total | 2 |
118 | infero-septal | 1 |
119 | noregestrel | 1 |
120 | inferior-wall | 1 |
121 | not-in-small-cell | 1 |
122 | solutol | 1 |
123 | 3'-hydroxyl-4'-methylphenyl | 1 |
124 | mmhg/gram | 1 |
125 | 5.2-cm | 1 |
126 | 6.5-cm | 1 |
127 | ≥jia-american | 1 |
128 | white/american | 1 |
129 | egfr/human | 1 |
130 | salivaricin | 1 |
131 | cefotaxime/heparin | 1 |
132 | 3-17i-saporin | 3 |
133 | non-first-generation | 4 |
134 | antibody-depletion | 1 |
135 | spectron | 16 |
136 | 1o | 4 |
137 | crescendo-decresendo | 1 |
138 | quadripolar | 20 |
139 | lv/univentricular | 2 |
140 | biscover | 4 |
141 | placebo/lower | 1 |
142 | post-cpr | 1 |
143 | bromoacetylarenes | 1 |
144 | abbreviates | 1 |
145 | nonparticipators | 1 |
146 | radioantagonists | 1 |
147 | dysynchronous | 1 |
148 | dyssychronous | 1 |
149 | m918t | 1 |
150 | 4-beat | 1 |
151 | fatigue-predominant | 3 |
152 | target-equivalent | 1 |
153 | variability-equivalent | 1 |
154 | g3-persistent | 1 |
155 | flatstent/flatstent | 1 |
156 | pharmaburst | 1 |
157 | period/lv | 2 |
158 | ↓lv | 1 |
159 | period/rv | 2 |
160 | non-fsw | 2 |
161 | technetium-99m-hmpao-hexamethly | 1 |
162 | subpulmonary | 21 |
163 | om/am/hctz | 4 |
164 | flatstent™ | 2 |